Contineum Therapeutics

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

5 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

World Politics & Diplomacy 06 Oct 2026, 10:18 AM IST

Europe’s Space Spending Surge Tests Glasgow’s Satellite Ambitions

Europe is committing billions of euros to space infrastructure, defence-adjacent capabilities and satellite services, sharpening the competition for industrial hubs that want a share of the boom. Glasgow, now one of the UK’s most active satellite manufacturing centres, faces a critical question: can a city built on entrepreneurial momentum scale fast enough without deeper state backing?

By RDU Global Wire6 min read

Startups & Venture CapitalJust now (02:02 PM IST)

Beam Therapeutics Sues Chinese Biotech and VC-Backed Startup Over Alleged IP Theft

Beam Therapeutics has filed suit against a Chinese biotech company and a venture-capital-backed startup, alleging theft of intellectual property tied to its gene-editing technology, according to STAT. The case adds to mounting tensions over biotech innovation, cross-border technology transfer, and the protection of proprietary research in a sector where patents and trade secrets are central to valuation.

6 min readRead →

Global Health & Biotech06 Oct 2026, 08:29 AM IST

AstraZeneca CEO Says Summit Drug Could Anchor Next Wave of Cancer Combinations After $2 Billion Bet

AstraZeneca Chief Executive Pascal Soriot said Summit Therapeutics’ cancer drug could become a foundation for the next generation of combination therapies, underscoring why the Anglo-Swedish drugmaker has committed about $2 billion to the biotech. The comments come as AstraZeneca and Daiichi Sankyo move to test Summit’s ivonescimab alongside Datroway, a sign that large pharmaceutical groups are racing to secure the most promising assets in oncology.

5 min readRead →

Clean Energy & Climate Transition04 Oct 2026, 08:22 AM IST

Poxvirus Study Reveals a Human Gene It Has Kept and Repurposed for Survival

Scientists have identified a poxvirus carrying a stolen human gene and, unusually, showing signs that it has retained and refined the genetic material over time rather than discarding it. The finding offers a rare window into how viruses can borrow from their hosts and adapt those genes for their own biology, with implications for virology, evolutionary research, and the design of future therapeutics.

5 min readRead →

Global Health & BiotechJust now (03:00 PM IST)

Foghorn Cuts 40% of Staff After Lilly Ends Cancer Pact on Data Concerns

Foghorn Therapeutics is laying off about 40% of its workforce after Eli Lilly terminated a cancer drug collaboration that had been a key strategic and financial pillar for the biotech company. The collapse of the partnership, reportedly tied to concerns over data quality, has intensified pressure on Foghorn’s pipeline and sent its shares sharply lower as investors reassess the company’s near-term prospects.

5 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Contineum Therapeutics:

United States(1)RDU Global(1)Glasgow(1)European Union(1)Europe(1)Bristol Myers Squibb(1)